Literature DB >> 737000

The amyloidosis of juvenile rheumatoid arthritis--comparative studies in Polish and American children. I. Levels of serum SAA protein.

A M Filipowicz-Sosnowska, K Roztropowicz-Denisiewicz, C J Rosenthal, J Baum.   

Abstract

Serum SAA concentration was determined by radioimmunoassay in 21 Polish children with amyloidosis secondary to juvenile rheumatoid arthritis (JRA). The results were compared to controls and children with JRA in Polish populations (where amyloidosis is a frequent complication of JRA) as well as to American children with JRA (where amyloidosis in JRA has been observed only sporadically) and American control children. No significant differences of SAA protein levels were found in the amyloidotic Polish children when compared to JRA Polish and American children. However, significantly higher levels of SAA protein were present in amyloidotic Polish children when compared to the control Polish and American group. High serum SAA protein concentration in JRA children did not necessarily correlate with the presence of secondary amyloidosis. Other mechanisms are probably involved in the development of amyloidosis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 737000     DOI: 10.1002/art.1780210615

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  5 in total

1.  Where has secondary amyloid gone?

Authors:  B P Hazenberg; M H van Rijswijk
Journal:  Ann Rheum Dis       Date:  2000-08       Impact factor: 19.103

Review 2.  Reactive amyloidosis.

Authors:  J David; P Woo
Journal:  Arch Dis Child       Date:  1992-03       Impact factor: 3.791

3.  Gout and amyloidosis.

Authors:  Y Levo; O Shalev; E Rosenmann; M Eliakim
Journal:  Ann Rheum Dis       Date:  1980-12       Impact factor: 19.103

4.  Serum amyloid protein levels in south american children with rheumatoid arthritis: a co-operative study.

Authors:  M A Scheinberg; O Hubscher; O G Morteo; M D Benson
Journal:  Ann Rheum Dis       Date:  1980-06       Impact factor: 19.103

Review 5.  Pathophysiology and treatment of systemic amyloidosis.

Authors:  Julian D Gillmore; Philip N Hawkins
Journal:  Nat Rev Nephrol       Date:  2013-08-27       Impact factor: 28.314

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.